Media Newsroom of

Bridge Therapeutics

Birmingham, AL

Bridge Therapeutics, Inc. is an innovative development-stage pharmaceutical company pursuing FDA and EMA approval of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login